Menopause Flashcards

(37 cards)

1
Q

The WHO has defined the ______ as signifying
the permanent cessation of menstruation, resulting
from the loss of ovarian follicular activity

A

menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Premenopausal: up to ______ years before the

last menstrual period.

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

_________ the presence of early
menopausal symptoms with vaginal bleeding (usually
irregular).

A

Perimenopausal:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Postmenopausal: the phase beginning

_________ months after the last menstrual cycle.

A

12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Osteoporosis is
usually addressed in the context of the menopause
because it is found mainly in postmenopausal middleaged
and elderly women and can be largely prevented
by correcting________

A

oestrogen deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In the postmenopause phase, FSH
rises to levels _______times that of the follicular phase
of the cycle while ______ levels rise about threefold

A

10–15

LH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Contraception is advisable for_______ after the
last period for women over 50 years and two years
for those under 50 years

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The modern treatment of HRT at the menopause
not only reduces climacteric symptoms and enhances
the quality of life in the short term but also reduces
the risk of
1
2
3

A

bowel cancer, osteoporosis and fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Emphasis of the The Women’s Health Initiative study

Points to emphasise:

• there is no firm evidence of an increased risk of
breast cancer with use of HRT_______
• HRT cannot be recommended in _______
• women choosing to cease HRT should reduce
their dose _________

A

<5 years

asymptomatic menopausal women to prevent osteoporosis

gradually over 2–3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
In 2013, an international meeting formulated
a Global Consensus Statement on Menopause
Hormone Therapy (MHT). What is their endorsement?
A

A key recommendation
is that ‘MHT is the most effective treatment for vasomotor symptoms associated with menopause at
any age, but benefits are more likely to outweigh risks
for symptomatic women before the age of 60 years or
within 10 years after menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HRT in menopause

If _______, the OCP cyclical HRT (noncontraceptive)
or progestogen-only regimens such as
LNG-IUD can be used.

If menopausal—use ______

A

perimenopausal

HRT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

_________ and gels are the most favoured estrogen Tx `worldwide

A

Transdermal patches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

______ and ______ are usually restricted
to women who have mild menopausal symptoms
and a dry vagina, or who cannot tolerate parenteral
medication

A

Vaginal creams or tablets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

________ is given to women with a uterus and
may be given continuously or cyclically. If it is not
given, many women will develop hyperplasia of
the uterus and there is a 5–10 times increased risk
of endometrial cancer with unopposed oestrogen

A

Progestogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What and how is Progesteron Tx given for post menopausal women?

A

If given cyclically (postmenopausal) it
is given for the first to the fourteenth day of the
calendar month, generally as Provera or Primolut
N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Progestogen alone can be given for menopausal

symptoms in a woman with an_______

A

oestrogen-dependent tumour

17
Q

Progestogens should be given in the smallest

possible dose, to prevent _______

A

endometrial hyperplasia.

18
Q

A progestogen must be used with oestrogen if the

woman still has a ________

19
Q

________ is usually reserved for women whose
libido does not improve with HRT and those with
a premature menopause but this indication is
controversial and it should be used with caution
because of the lack of data about adverse effects

20
Q

How to give Testosterone in menopausal women

A

If available it is given as an implant of 50 mg and will

last 3–12 months

21
Q

What to give in addition while on Testosterone Tx

A

An oestrogen implant of 50 mg should be given concurrently

22
Q

This is a selective tissue oestrogenic activity regulator
with combined oestrogenic, progestogenic and
androgenic properties that can be used as an excellent
alternative to conventional HRT in postmenopausal
women.

23
Q
Positive effects of Tibolone are on 
1
2
3
4
A

vasomotor and urogenital symptoms, sexual function, bone density and fracture risk

24
Q

When is Tibolone given?

A

It should be considered for women who

are surgically postmenopausal or who have not had a natural menstrual bleed for at least 12 months.

25
AE of Tibolone
Adverse effects with breakthrough bleeding and | virilisation are a concern
26
Dose of Tibolone
Dose: tibolone 2.5 mg (o) daily
27
The main absolute contraindications of HRT are:
active oestrogen-dependent neoplasms, such as endometrial and breast cancer, deep venous thrombosis, acute thrombophlebitis and undiagnosed, abnormal vaginal bleeding
28
HRT is protective for_____ but not ____
bowel cancer ovarian cancer
29
It must be emphasised that HRT, especially the_______, is not a contraceptive.
combined | sequential formulation
30
The main short-term | risk of oral HRT in women aged 50–59 is _____
venous | thromboembolism
31
How to manage premenstrual syndrome
decrease progestogen dose or change to alternative progestogen
32
What is the cause of Nausea and breast disorders in postmenopausal women?
initial sensitivity to oestrogen
33
How to manage nausea and breast DO?
reduce oestrogen to starting or low dose or use intravaginal oestrogen
34
Heavy bleeding Action: _______ Breakthrough bleeding Action: ________ Irregular bleeding Action: _______ Intolerance of bleeding Action: use continuous regimen No bleeding Action: reassure that this is not a problem
decrease oestrogen increase progestogen investigate + endometrial sampling
35
A useful working rule is to aim for treatment for a maximum of ______and then review with an aim of using HRT for _______ if appropriate for that person
2 years 5 years
36
Current evidence is that combined oestrogen and progestogen therapy will not increase the risk of breast cancer for up to _______ and oestrogenonly therapy will not increase risk for at least _____
5 years of use, 7.2 years
37
Vaginal dryness The first-line therapy is a non-hormonal preparation such as _______. If these are ineffective, _________ preparations can be useful,
Replens or K-Y Gel low-dose vaginal oestrogen